Back to 
Avoro Capital Advisors LLC
Avoro Capital Advisors LLC
VRTX
Showing 0 of 4 quarters
Position history for Avoro Capital Advisors LLC's holdings in VERTEX PHARMACEUTICALS INC
No. Avoro Capital Advisors exited its VRTX (Vertex Pharmaceuticals) position in Q4 2021. Its Q3 2021 13F listed 664,000 shares worth $120.4M. Avoro Capital Advisors first reported VRTX in Q1 2021 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.